Literature DB >> 16777671

Lipids and the pathogenesis of Alzheimer's disease: is there a link?

Michelle M Mielke1, C G Lyketsos.   

Abstract

Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder characterized pathologically by amyloid-beta plaques, neurofibrillary tangles and neuronal loss. Its fundamental cause(s) and the pathological cascades leading to clinical symptoms remain unknown. Lipids and lipid peroxidation products have important roles in the homeostasis of the central nervous system. As well, lipid transport genes and vascular changes associated with peripheral dyslipidemia have been associated with an increased risk of AD. The present review discusses ways in which lipids may be involved in the pathogenesis of AD-associated neurodegeneration through their roles as neuronal structural components, cell modulators, or second messengers. Given the many possibilities through which lipids may be directly involved in or contribute to the pathogenesis of AD, the use of lipids as biomarkers for disease progression is discussed, as are other avenues for future research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777671     DOI: 10.1080/09540260600583007

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  22 in total

Review 1.  Amyloid-β production: major link between oxidative stress and BACE1.

Authors:  Elena Tamagno; Michela Guglielmotto; Debora Monteleone; Massimo Tabaton
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

2.  Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

Authors:  Willam T Wang; Breeya A Tailor; David S Cohen; Xudong Huang
Journal:  EC Pharmacol Toxicol       Date:  2019-06-21

Review 3.  Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?

Authors:  Michelle M Mielke; Constantine G Lyketsos
Journal:  Neuromolecular Med       Date:  2010-06-23       Impact factor: 3.843

Review 4.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

5.  Serum sphingomyelins and ceramides are early predictors of memory impairment.

Authors:  Michelle M Mielke; Veera Venkata Ratnam Bandaru; Norman J Haughey; Peter V Rabins; Constantine G Lyketsos; Michelle C Carlson
Journal:  Neurobiol Aging       Date:  2008-05-05       Impact factor: 4.673

6.  Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors.

Authors:  Michela Guglielmotto; Luca Giliberto; Elena Tamagno; Massimo Tabaton
Journal:  Front Aging Neurosci       Date:  2010-02-09       Impact factor: 5.750

7.  Potential of ezetimibe in memory deficits associated with dementia of Alzheimer's type in mice.

Authors:  Yogita Dalla; Nirmal Singh; Amteshwar Singh Jaggi; Dhandeep Singh; Pooja Ghulati
Journal:  Indian J Pharmacol       Date:  2009-12       Impact factor: 1.200

8.  Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?

Authors:  Michelle M Mielke; Norman J Haughey
Journal:  Clin Lipidol       Date:  2012-10

Review 9.  Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.

Authors:  Joshua A Sonnen; John C Breitner; Mark A Lovell; William R Markesbery; Joseph F Quinn; Thomas J Montine
Journal:  Free Radic Biol Med       Date:  2008-04-24       Impact factor: 7.376

Review 10.  Recent advances in the application of metabolomics to Alzheimer's Disease.

Authors:  Eugenia Trushina; Michelle M Mielke
Journal:  Biochim Biophys Acta       Date:  2013-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.